Sarah E Yentz (Sarah Yentz)

Publication Activity (10 Years)

Years Active: 2018-2021
Publications (10 Years): 2

Top Topics

Patient Satisfaction

Municipal Solid Waste

Childhood Cancer

Top Venues

JCO oncology practice

BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy

This page only lists publications with an associated author ORCID identifier.

Publications

Cindy Y Jiang, Garth W Strohbehn, Rachel M Dedinsky, Shelby M Raupp, Brittany M Pannecouk, Sarah E Yentz, Nithya Ramnath
Teleoncology for Veterans: High Patient Satisfaction Coupled With Positive Financial and Environmental Impacts. JCO oncology practice 17 (9) (2021)
Sarah E Yentz, David Smith
Indoleamine 2,3-Dioxygenase (IDO) Inhibition as a Strategy to Augment Cancer Immunotherapy. BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy 32 (4) (2018)